Table 2 T 1 sensitivity and specificity tables for changes in RIF-1 tumour volume following everolimus or patupilone treatment
A. Everolimus: using a ΔT1 of −8% | |||
|---|---|---|---|
ΔTVol | |||
ΔT1 | Positive | Negative | Total |
Positive | 5 | 3 | 8 |
Negative | 0 | 5 | 5 |
Total | 5 | 8 | 13 |
B. Patupilone: using a ΔT1 of −8%. | |||
ΔTVol | |||
ΔT 1 | Positive | Negative | Total |
Positive | 7 | 3 | 10 |
Negative | 0 | 10 | 10 |
Total | 7 | 13 | 20 |